Raleigh, North Carolina; Revenue - Utility, Water/Sewer Jan 99

  • ID: 2086163
  • January 1999
  • Region: North Carolina
  • Standard & Poors
1 of 3

The rating on Raleigh, N.C.'s bonds are secured by a first lien on net revenues of the combined utility system and are on parity with the 1996 bonds. The rating reflects the system's: Strong area economy, Sufficient capacity for the next 20 years, Competitive rates and sufficient rate flexibility, Strong coverage of senior-lien debt, and Modest future capital needs. Raleigh serves about 89,000 retail water and sewer customers in an area that exhibits low unemployment and healthy growth and benefits from its proximity to the Research Triangle Park, which attracts high-paying, technology intensive manufacturing companies to the area. Large employers include Duke University Medical Center, IBM, and two state universities. Employment has grown 2%-3% annually since 1995, and unemployment rates...

Companies mentioned in this report are:
- Raleigh

Action: New Rating

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research Type: Full Analysis

Note: Product cover images may vary from those shown
2 of 3


Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown


  • Quick Help: This Credit Rating Report will be emailed to you.


If you have a more general question about our products please try our



Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer, Inc.